Susquehanna Fundamental Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-51,703
Closed -$1.86M 1232
2024
Q4
$1.86M Buy
+51,703
New +$1.75M 0.03% 545
2024
Q2
$3.14M Buy
77,833
+40,128
+106% +$1.67M 0.07% 316
2024
Q1
$1.34M Buy
+37,705
New +$1.01M 0.06% 297
2022
Q4
Sell
-32,935
Closed -$1.58M 1482
2022
Q3
$1.58M Buy
+32,935
New +$1.81M 0.03% 657
2022
Q1
$9.28M Buy
79,778
+22,472
+39% +$2.62M 0.18% 142
2021
Q4
$8.63M Buy
57,306
+3,225
+6% +$435K 0.23% 103
2021
Q3
$6.46M Buy
54,081
+42,038
+349% +$4.63M 0.12% 229
2021
Q2
$1.17M Sell
12,043
-10,355
-46% -$923K 0.02% 786
2021
Q1
$1.98M Sell
22,398
-7,452
-25% -$693K 0.03% 660
2020
Q4
$2.86M Sell
29,850
-4,223
-12% -$435K 0.05% 513
2020
Q3
$3.87M Buy
34,073
+2,173
+7% +$228K 0.12% 244
2020
Q2
$3.16M Buy
+31,900
New +$2.55M 0.15% 173

Other funds holding TNDM

Susquehanna Fundamental Investments's TNDM Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 51,703 shares — an estimated $1.86M sold.

Susquehanna Fundamental Investments first reported a position in TNDM in Q2 2020 and held it in 12 quarters. The position peaked at $9.28M in Q1 2022. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Susquehanna Fundamental Investments reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 51,703 Tandem Diabetes Care shares in Q1 2025, an estimated $1.86M.
  • Susquehanna Fundamental Investments first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 12 quarters.
  • Susquehanna Fundamental Investments's Tandem Diabetes Care position peaked at $9.28M in Q1 2022.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.